Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Devonec

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
World Journal of Urology|May 20, 2006
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxinAbdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps, et al.
International Journal of Radiation Oncology, Biology, Physics|January 8, 2013
Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wallOlivier Chapet, Corina Udrescu, Marian Devonec, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)]Alexandre De la Taille, Marc Fourmarier, Francois Desgrandchamps, et al.
Urology|October 12, 2016
Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate CancerRomain Boissier, Corina Udrescu, Xavier Rebillard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2006
[Role of prostatic stents and transurethral microwave thermotherapy in the treatment of voiding disorders related to benign prostatic hyperplasia (CTMH-AFU forum 2005)], Christian Saussine, Marian Devonec, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapyOlivier Chapet, Corina Udrescu, Ronan Tanguy, et al.
International Journal of Molecular Sciences|August 1, 2014
Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressivenessLucile Tallon, Devillier Luangphakdy, Alain Ruffion, et al.
BJU International|January 22, 2009
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a reviewAurélien Descazeaud, Gregoire Robert, Abdel Rahmene Azzousi, et al.
World Journal of Urology|June 26, 2010
Impact of oral anticoagulation on morbidity of transurethral resection of the prostateAurélien Descazeaud, Gregoire Robert, Souhil Lebdai, et al.
Clinical Biochemistry|April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomyBenoit You, Paul Perrin, Gilles Freyer, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
World Journal of Urology|May 20, 2006
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxinAbdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps, et al.
International Journal of Radiation Oncology, Biology, Physics|January 8, 2013
Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wallOlivier Chapet, Corina Udrescu, Marian Devonec, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)]Alexandre De la Taille, Marc Fourmarier, Francois Desgrandchamps, et al.
Urology|October 12, 2016
Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate CancerRomain Boissier, Corina Udrescu, Xavier Rebillard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2006
[Role of prostatic stents and transurethral microwave thermotherapy in the treatment of voiding disorders related to benign prostatic hyperplasia (CTMH-AFU forum 2005)], Christian Saussine, Marian Devonec, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapyOlivier Chapet, Corina Udrescu, Ronan Tanguy, et al.
International Journal of Molecular Sciences|August 1, 2014
Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressivenessLucile Tallon, Devillier Luangphakdy, Alain Ruffion, et al.
BJU International|January 22, 2009
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a reviewAurélien Descazeaud, Gregoire Robert, Abdel Rahmene Azzousi, et al.
World Journal of Urology|June 26, 2010
Impact of oral anticoagulation on morbidity of transurethral resection of the prostateAurélien Descazeaud, Gregoire Robert, Souhil Lebdai, et al.
Clinical Biochemistry|April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomyBenoit You, Paul Perrin, Gilles Freyer, et al.
Pageof 4